← Back to Search

MEDIC site for Pulmonary Embolism

N/A
Waitlist Available
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months pre-intervention, up to 18 months post-intervention
Awards & highlights

Study Summary

This trial is testing a new way to improve the treatment of patients with pulmonary embolism to see if it can help avoid unnecessary hospital stays.

Who is the study for?
This trial is for individuals who arrive at the emergency department with a pulmonary embolism (PE), which is a blockage in one of the lung's arteries. The study aims to include those who might benefit from improved care processes.Check my eligibility
What is being tested?
The intervention being tested involves new procedures for managing PE patients in the emergency department, with a focus on reducing unnecessary hospital admissions while maintaining patient safety and quality of care.See study design
What are the potential side effects?
Since this trial focuses on health care management rather than medication or medical procedures, there are no direct side effects associated with it. However, changes in care may affect patient experience.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months pre-intervention, up to 18 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months pre-intervention, up to 18 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in proportion of patients discharged home from Emergency Department (ED)

Trial Design

1Treatment groups
Experimental Treatment
Group I: MEDIC siteExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,833 Previous Clinical Trials
47,306,482 Total Patients Enrolled
19 Trials studying Pulmonary Embolism
149,741 Patients Enrolled for Pulmonary Embolism
University of MichiganLead Sponsor
1,794 Previous Clinical Trials
6,373,902 Total Patients Enrolled
1 Trials studying Pulmonary Embolism
5,000 Patients Enrolled for Pulmonary Embolism
Geoff BarnesStudy ChairUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase for this investigation currently ongoing?

"Information available on clinicaltrials.gov shows that the current trial is not open for patient recruitment. Despite being originally posted on March 1st, 2024 and last revised on March 13th, 2024, it is no longer seeking participants. However, there are a substantial number of 297 ongoing clinical trials actively enrolling volunteers at this moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE)
Geoffrey Barnes 2024. "Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06312332.
All > Pulmonary Embolism
~9 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top